Venus Remedies, a leading research-based global pharmaceutical company has won the prestigious Patent Award in Silver category for the year 2011-12 in the valedictory function of India-Asia Pacific Pharma Business Meet, organized by Pharmexcil in Hyderabad.
The company has won this prestigious award for the second year in a row for its commendable contributions towards Research & Development, demonstrated by patent grants in 2011-12.
Venus Remedies has received four patents in this fiscal year with two patents each for Sulbactomax and Vancoplus. These patent grants from USA, Japan, Australia and New Zealand would augment company’s business plans in these countries. Till now, the company has received more than 80 patents for its various novel research formulations covering 51 countries across the globe.
Venus Remedies has established its presence across the world through a portfolio of more than 75 injectables and 13 patent protected novel research products catering to the critical care segment and super specialty segments. The company has special focus towards the growing epidemic of Antimicrobial Resistance and Oncology. Besides this, the company has 51 product registrations in the regulated markets with 108 CTDs filed for seven products and 400+ market authorizations in the emerging countries.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1483.75 |
Dr. Reddys Lab | 5947.30 |
Cipla | 1347.70 |
Zydus Lifesciences | 958.90 |
Lupin | 1580.00 |
View more.. |